|
Secondary prevention
Citations 281-290 of 568 total displayed.
|
Past content
(since Feb 1999):
|
- Articles
Randomized, Placebo-Controlled Trial of Dalteparin for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
- Alain Leizorovicz, Alexander T. Cohen, Alexander G.G. Turpie, Carl-Gustav Olsson, Paul T. Vaitkus, Samuel Z. Goldhaber for the PREVENT Medical Thromboprophylaxis Study Group
Circulation published August 2, 2004, doi:10.1161/01.CIR.0000138928.83266.24
[Abstract]
- Arrhythmia/Electrophysiology
Fish Intake and Risk of Incident Atrial Fibrillation
- Dariush Mozaffarian, Bruce M. Psaty, Eric B. Rimm, Rozenn N. Lemaitre, Gregory L. Burke, Mary F. Lyles, David Lefkowitz, and David S. Siscovick
Circulation 2004;110:368-373; published online before print as doi:10.1161/01.CIR.0000138154.00779.A5
[Abstract]
[Full text]
- Coronary Heart Disease
Effect of Atorvastatin on Risk of Recurrent Cardiovascular Events After an Acute Coronary Syndrome Associated With High Soluble CD40 Ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study
- Scott Kinlay, Gregory G. Schwartz, Anders G. Olsson, Nader Rifai, William J. Sasiela, Michael Szarek, Peter Ganz, Peter Libby for the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering Study Investigators
Circulation 2004;110:386-391; published online before print as doi:10.1161/01.CIR.0000136588.62638.5E
[Abstract]
[Full text]
- Articles
Randomized Trial of Atorvastatin for Reduction of Myocardial Damage During Coronary Intervention. Results From the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) Study
- Vincenzo Pasceri, Giuseppe Patti, Annunziata Nusca, Christian Pristipino, Giuseppe Richichi, Germano Di Sciascio on behalf of the ARMYDA Investigators
Circulation published July 26, 2004, doi:10.1161/01.CIR.0000137828.06205.87
[Abstract]
- Arrhythmia/Electrophysiology
Heart Failure and Sudden Death in Patients With Tachycardia-Induced Cardiomyopathy and Recurrent Tachycardia
- Pamela Nerheim, Sally Birger-Botkin, Lubna Piracha, and Brian Olshansky
Circulation 2004;110:247-252; published online before print as doi:10.1161/01.CIR.0000135472.28234.CC
[Abstract]
[Full text]
- Coronary Heart Disease
Regression of Coronary Atherosclerosis by Simvastatin: A Serial Intravascular Ultrasound Study
- Lisette Okkels Jensen, Per Thayssen, Knud Erik Pedersen, Steen Stender, and Torben Haghfelt
Circulation 2004;110:265-270; published online before print as doi:10.1161/01.CIR.0000135215.75876.41
[Abstract]
[Full text]
- Articles
Fish Intake and Risk of Incident Atrial Fibrillation
- Dariush Mozaffarian, Bruce M. Psaty, Eric B. Rimm, Rozenn N. Lemaitre, Gregory L. Burke, Mary F. Lyles, David Lefkowitz, and David S. Siscovick
Circulation published July 19, 2004, doi:10.1161/01.CIR.0000138154.00779.A5
[Abstract]
- Articles
Temporal Trends in Coronary Heart Disease Mortality and Sudden Cardiac Death From 1950 to 1999. The Framingham Heart Study
- Caroline S. Fox, Jane C. Evans, Martin G. Larson, William B. Kannel, and Daniel Levy
Circulation published July 19, 2004, doi:10.1161/01.CIR.0000136993.34344.41
[Abstract]
- Articles
Effect of Atorvastatin on Risk of Recurrent Cardiovascular Events After an Acute Coronary Syndrome Associated With High Soluble CD40 Ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study
- Scott Kinlay, Gregory G. Schwartz, Anders G. Olsson, Nader Rifai, William J. Sasiela, Michael Szarek, Peter Ganz, Peter Libby for the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators
Circulation published July 19, 2004, doi:10.1161/01.CIR.0000136588.62638.5E
[Abstract]
- Articles
Regression of Coronary Atherosclerosis by Simvastatin. A Serial Intravascular Ultrasound Study
- Lisette Okkels Jensen, Per Thayssen, Knud Erik Pedersen, Steen Stender, and Torben Haghfelt
Circulation published July 6, 2004, doi:10.1161/01.CIR.0000135215.75876.41
[Abstract]
|
|
